CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822082553
- Phone
- (781) 222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- 4 Planned sale Chief Strategy Officer sold 5,698 shares at an average $24.04 ($137,008)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Strategy Officer sold 15,575 shares at $18.05 ($281,129)
- 4 Open-market sale President & Chief R&D Officer sold 7,861 shares at $18.05 ($141,891)
- 4 Open-market sale Chief Dev. Op. Officer sold 12,207 shares at $18.05 ($220,336)
- 4 Open-market sale Chief Operating Officer sold 10,775 shares at $18.05 ($194,489)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 6 of 16 · 316 filings